market.news daily briefing

China Daily Briefing

Tuesday, 27 October 2026

⚖️ CSI 300 proxy -0.03% in a split session: EV/Mobility (+0.66%) and Fintech (+0.62%) gain traction while Internet/Platform (-0.89%) drags BABA/JD complex lower

China's market closed at virtual stasis — iShares China Large-Cap -0.03%, KraneShares China Internet -0.30% — but the sector divergence told a more nuanced story. EV/Mobility gained +0.66% as XPeng's +1.86% move suggested the electric vehicle delivery cycle is getting institutional attention ahead of October delivery data — a monthly catalyst that increasingly moves the EV sub-sector. Internet/Platform's -0.89% drag reflected ongoing regulatory uncertainty with iQiyi (IQ) falling -4.49% and NetEase (NTES) dropping -3.58%, with Bilibili (BILI) -1.72% also soft; the content platform complex continues to trade at a risk discount relative to e-commerce and fintech. SCMP Business reported that ByteDance's Zhang Yiming tops China's rich list at $99.7bn as AI fuels tech fortunes — an ironic contrast to a session where public-market China tech faced selling pressure, underlining the private-vs-public valuation divergence in Chinese tech assets.

By the numbers

iShares China Large-CapFXI

32.5

-0.03%(-0.01)

KraneShares China InternetKWEB

23.13

-0.30%(-0.07)

3 things that moved markets

ByteDance's Zhang Yiming: $99.7B as AI Fuels China Tech Fortunes

ByteDance's Zhang Yiming topped China's rich list at $99.7 billion, per SCMP Business, as AI-driven advertising revenue and TikTok's global monetization lifted private-market valuations for ByteDance. The wealth concentration story has market implications: ByteDance's dominance in China's AI/advertising stack is increasingly seen as the key risk to Alibaba and Tencent's ad revenue, and this session's IQ -4.49% and NTES -3.58% weakness reflects ad budget compression in the content platform sector. For investors tracking the private-to-public Chinese tech convergence, ByteDance's pre-IPO valuation premium signals that Baidu and Alibaba — both public, both below $99bn market cap — are trading at a structural discount to the most dynamically growing private AI business in China.

Read at SCMP Business ↗

Hengrui Posts 89% Q3 Profit Rise: China Pharma Beats Expectations

China's Hengrui Medicine posted an 89% rise in third-quarter net profit, beating estimates, per SCMP Business — the kind of earnings beat that the China pharma sector has been delivering consistently as domestic drug approvals accelerate and global ADR licensing deals multiply. Hengrui's beat is structurally important: it's the largest domestic innovative drug company in China, and its success signals that the NMPA (National Medical Products Administration) approval pathway for next-gen oncology and autoimmune drugs is functioning effectively. The China pharma divergence from internet/platform weakness today (EV/Mobility and Fintech gaining alongside pharma) suggests institutional rotation is underway: away from regulatory-overhang sectors toward innovation and export-oriented businesses with clear earnings trajectories.

Read at SCMP Business ↗

Pop Mart Revenue Drops 45-50%: Labubu IP Cycle Weakens Globally

Pop Mart's 45-50% revenue decline as Labubu toy sales weakened across major markets per SCMP Business — a significant deceleration for one of China's most successful IP-export stories. The Labubu phenomenon had driven Pop Mart's market cap to extraordinary multiples; a 45% revenue decline suggests the IP cycle is shorter than management guided, and the blind-box collectible model faces saturation faster in Western markets than in domestic China. The broader consumer sector (-0.44% today) reflects this tension: China has proven it can manufacture global IP (Labubu, gaming characters, mobile gaming) but sustaining consumer attachment over a 3+ year horizon remains the structural challenge; SCMP's coverage frames this as a read-through for all China IP/consumer export plays.

Read at SCMP Business ↗

Top movers

Gainers (5)

Losers (5)

Sector heatmap

Smart-money note

China's institutional signal today was selective rotation: smart money buying EV/Mobility (XPeng +1.86%, XPEV Fintech +0.62%) while letting internet/content (IQ -4.49%, NTES -3.58%) drift lower. The PBOC's MLF operations this week have been neutral-to-supportive, injecting ¥700bn net, which provides liquidity backstop without signaling a rate-cutting urgency — that baseline supports the market's reluctance to price in severe downside even as platform stocks face regulatory overhang. Stock Connect Northbound flow direction is today's key missing data point: if foreign institutional inflows were net positive (as they have been for 6 of the past 8 sessions), the -0.03% session represents buying absorption, not selling pressure — a structurally constructive reading for tomorrow's open. The regulatory backdrop remains the dominant second-order risk: SCMP reported that China handed a former regulator a suspended death sentence for $65M in bribery — a signal that Xi's anti-corruption campaign extends into the financial regulatory class, which historically precedes new financial sector policy announcements. Watch the PBOC's LPR announcement cycle and any NDRC 'basket of policies' follow-up for the property sector; bank lending data for October (due mid-November) will be the institutional positioning reset signal.

What to watch tomorrow

XPeng October Deliveries

XPeng's +1.86% session suggests the market expects strong October delivery numbers (due in early November); Li Auto and BYD delivery data will set the tone for the entire EV/Mobility sector re-rating.

Stock Connect Northbound Flow

With index near flat, tomorrow's Northbound (foreign) flow is the directional tell — net positive above +HK$2bn would confirm institutional accumulation under the 20-day moving average resistance.

IQ/NTES Regulatory Catalyst

iQiyi -4.49% and NetEase -3.58% look like more than one-day sector rotation; check for any Cyberspace Administration of China (CAC) content platform announcements or gaming license batches tomorrow morning.

Browse all China briefings →